seizures

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Abstract Adults with ADHD describe self-medicating with cannabis, with some reporting a preference for cannabis over ADHD medications. A small number of psychiatrists in the US prescribe cannabis medication for ADHD, despite there being no evidence from randomised controlled studies. The EMA-C trial (Experimental Medicine in ADHD-Cannabinoids) was a pilot randomised placebo-controlled experimental study of …

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Read More »

Sep 24 2019

Medical Marijuana and Epilepsy

ABSTRACT Studies in the U.S. of Epidiolex (a plant-based CBD formulation) have been ongoing for a number of years. Data from these studies has helped provide evidence that led to the FDA approval of this product on June 25, 2018. Epidiolex is a purified (> 98% oil-based) CBD extract from the cannabis plant. It is …

Medical Marijuana and Epilepsy Read More »

Aug 26 2019

Managing drug-resistant epilepsy: challenges and solutions

ABSTRACT To date, there are restricted data assessing chronic models of epilepsy as well as animal models of epileptogenesis. Some clinical evidence indicates that CBD is able to manage epilepsy in adults and children affected by refractory seizures, with a favorable side effect profile. Tzadok et al treated 74 pediatric patients, who were resistant to …

Managing drug-resistant epilepsy: challenges and solutions Read More »

Aug 25 2019

Epilepsy and Cannabis: A Literature Review

ABSTRACT Epilepsy is considered to be one of the most common non-communicable neurological diseases especially in low to middle-income countries. Approximately one-third of patients with epilepsy have seizures that are resistant to antiepileptic medications. Clinical trials for the treatment of medically refractory epilepsy have mostly focused on new drug treatments, and result in a significant …

Epilepsy and Cannabis: A Literature Review Read More »

Aug 25 2019

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Medical Marijuana and Epilepsy

Managing drug-resistant epilepsy: challenges and solutions

Epilepsy and Cannabis: A Literature Review

JOIN OUR NEWSLETTER

CONNECT WITH US

About

LEARN

Shop

These statements have not been evaluated by the FDA. This product is not intended diagnose, treat, cure or prevent disease.